Intracoronary delivery of Gd-DTPA and Gadophrin-2 for determination of myocardial viability with MR imaging

European Radiology

Volumn 11, Issue 5, 2001, Pages 876-883

  Ni, Y ^a   Pislaru, C ^a   Bosmans, H ^a   Pislaru, S ^a   Miao, Y ^a   Bogaert, J ^a   Dymarkowski, S ^a   Yu, J ^a   Semmler, W ^a   Van de Werf, F ^a   Baert, A L ^a   Marchal, G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Acute myocardial infarction; Intracoronary injection; Metalloporphyrins; MRI; Myocardial viability; Necrosis avid contrast agents

Indexed keywords

BIS GADOLINIUM MESOPORPHYRIN; CONTRAST MEDIUM; GADOLINIUM PENTETATE; PORPHYRIN DERIVATIVE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BALLOON CATHETER; CARDIOVASCULAR DISEASE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY; DOG; DOSE RESPONSE; ELECTROCARDIOGRAM; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PERFORMANCE; HISTOCHEMISTRY; IN VIVO STUDY; INTERMETHOD COMPARISON; INTRACORONARY INFUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; STATISTICAL ANALYSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; CONTRAST MEDIA; CORONARY VESSELS; DOGS; GADOLINIUM; GADOLINIUM DTPA; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MESOPORPHYRINS; METALLOPORPHYRINS; MYOCARDIAL INFARCTION;

EID: 17944383454     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300000791     Document Type: Article

References (37)

1. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium
2. Can technetium 99m-labeled sestamibi track myocardial viability?
3. Myocardial viability: Unresolved issues
4. Radionuclide detection of myocardial ischemia and myocardial viability: Is the glass half empty of half full?
5. Comparison of 201Tl scintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability
6. Myocardial viability: Contractile reserve or cell membrane integrity?
7. Mechanism of reperfusion damage after thrombolysis and 'direct PTCA'
8. Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options
9. Characterization of hibernating and stunned myocardium
10. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: Should the paradigm be expanded?
11. Perfusion-contraction mismatch during inotropic stimulation in hibernating myocardium
12. There may be more to myocardial viability than meets the eye
13. Magnetic resonance techniques for assessment of myocardial viability
14. Reperfusion and irreversible myocardial injury: Identification with a nonionic MR imaging contrast medium
15. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts
16. Normal and infarcted myocardium: Differentiation with cellular uptake of manganese at MR imaging in a rat model
17. Paramagnetic metalloporphyrins: From enhancers for malignant tumors to markers of myocardial infarcts
18. Photodynamic therapy in oncology: Mechanisms and clinical use
19. MnPcS4: A new MRI contrast enhancing agent for tumor localization in mice
20. Localization of metalloporphyrin induced "specific" enhancement in experimental liver tumors: Comparison of magnetic resonance imaging, microangiographic and histologic findings
21. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis
22. Metalloporphyrin enhanced magnetic resonance imaging of acute myocardial infarction
23. Paramagnetic metalloporphyrins: Infarct avid contrast agents for diagnosis of acute myocardial infarction by magnetic resonance imaging
24. Localization and determination of infarct size by Gd-mesoporphyrin enhanced MRI in dogs
25. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent
26. Myocardial viability
27. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats
28. Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model
29. Validation of intracoronary delivery of metalloporphyrin as an in vivo "histochemical staining" for myocardial infarction with MR imaging
30. Primary PTCA versus thrombolytic therapy: An evidence-based summary
31. Myocardial viability
32. Detection of hibernated myocardium using intracoronary technetium-99m-sestamibi
33. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction
34. The multifunctional therapy room of the future: Image guidance, interdisciplinarity, integration and impact on patient pathways
35. MRI contrast enhancement of necrosis by MP-2269 and Gadophrin-2 in a rat model of liver infarction
36. Mechanism of Gadophrin-2 accumulation in tumor necrosis
37. Necrosis avid contrast agents: Introducing nonporphyrin species